Issue link: https://viewer.e-digitaledition.com/i/1042775
ADOLESCENTS AND YOUNG ADULTS (AYAs) WITH ACUTE LYMPHOBL A STIC LEUKEMIA (ALL) HAvE BE T TER SURvIvAL R ATES IF TRE ATED IN PEDIATRIC CANCER CENTERS vERSUS ADULT CENTERS, ACCORDING TO A RECENT STUDY IN BLOOD ADVANCES. ONLY 5,960 NE W CA SES of ALL are expected in 2018, according to the American Cancer Society. However, the condition is a staple of practice for pediatric oncologists, as it is most likely to develop during childhood. For about a decade, researchers have known that AYAs — patients age 15–39 — fare better when treated with pediatric protocols, according to Lori Muffl y, MD, MS, Clinical Assistant Professor of Medicine–Blood and Marrow Transplantation at Stanford University. Recently, Dr. Muffl y and other researchers conducted a population-based study to assess the impact of care setting (pediatric versus adult cancer center) on outcomes in AYAs with ALL. The study is one of the fi rst to explore that issue, according to Elysia Alvarez, MD, MPH, Assistant Professor of Clinical Pediatrics at the University of California, Davis. It builds on a 2017 pilot study by a number of the same researchers that involved data from a regional cancer registry. COMPARING CARE SETTINGS For the more recent study, researchers used a statewide database, the California Cancer Registry, to fi nd 1,795 cases of ALL diag- nosed in AYAs from 2004 to 2014; they included 1,473 in their analysis. To determine each patient's treatment regimen, the group looked at facility-level data supplied to the state registry by regional registries. "[W]e took the really innovative approach of going into the text fi elds in the cancer registry ... to abstract treatment information to get at [patients'] initial regimens," says Theresa Keegan, PhD, MS, Associate Professor in the Division of Hematolog y and Oncology at the UC Davis Comprehensive Cancer Center and a co-author of the study. "This is not something that's commonly available in the cancer registry. We were able to show from our [2017 pilot study] and now this statewide work that we could capture this data and determine pediatric versus adult setting." for Certain Leukemia Patients Treated in Pediatric Cancer Centers Study Shows Survival Advantage BY THOMAS CROCKER 1 2

